FDA finds little evidence that a generic drug could help many people with autism The FDA is approving a generic drug for a very rare genetic disorder, but not for autism The Independent UK · Mar 10
Trump administration’s embattled FDA vaccine chief departing for the second time Vinay Prasad to leave in April after decisions involving vaccine reviews and specialty drugs for rare diseases The Guardian - US · Mar 6
'Usually everybody loves money': Trump's FDA chief to start giving bonuses for faster drug reviews The FDA lost about 20% of its workforce after Trump took office last year. Now it wants to shrink approvals from as long as 29 months to as low as six. Fortune · Mar 5
FDA to offer bonus payments to staffers who complete speedy drug reviews The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule The Independent UK · Feb 26
FDA proposes new system for approving customized drugs and therapies for rare diseases The Food and Drug Administration is proposing a system for approving customized drugs and medical treatments for patients with rare or hard-to-treat diseases The Independent UK · Feb 23
FDA Commissioner Says 'Everything Should Be Over the Counter.' Don't Count on Big Pharma To Lead the Way. A system that allows drug makers to profit from restricted access will never liberalize on its own—and patients will continue to bear the cost. Reason · Feb 19
FDA will drop two-study requirement for new drug approvals, aiming to speed access The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals The Independent UK · Feb 18
Companies can now claim 'no artificial colors' if they add plant-based color to food The U.S. Food and Drug Administration is relaxing rules that restrict when food companies can claim their products have no artificial colors The Independent UK · Feb 5
How To Speed Up the Search for Cures Through a Change in Probability Theory It seems likely the FDA would do well to accept more Bayesian reasoning in medical research. Reason · Feb 3
The FDA's Hands-Off Approach to Medical AI Is a Win for Health-Conscious Consumers AI-powered medical wearables and software are flourishing following the FDA’s new regulatory guidance. Reason · Jan 22
Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times The Independent UK · Jan 16
Top-down approach has Congress AWOL on FDA, experts say - Roll Call Since President Donald Trump took office, the FDA has lost about 20 percent of its staff through reduction-in-force efforts. Roll Call · Jan 8
‘She has no expertise’: the US medical community girds for Tracy Beth Høeg’s tenure at the FDA The Danish American who doubted Covid shots is meant to lead drug regulation – but has focused on vaccines The Guardian - US · Dec 31, 2025
After Nearly Three Decades, the US Might Finally Be Getting a New Sunscreen Filter SPF in America might finally catch up to Europe, Asia, and Australia. Marie Claire · Dec 12, 2025
Axios · Dec 4, 2025 FDA reaches "tipping point" after high-level departures Biotech and pharmaceutical companies rely on the FDA for guidance as they spend huge sums developing treatments.
Benzinga · Nov 27, 2025 Anthony Fauci Under Fresh Fire As FDA Chief Makary Argues COVID-19 Lab Leak Theory Was 'Massive Cover-Up:' 'It's A No Brainer...' The U.S. Food and Drug Administration’s (FDA) top official ignited fresh debate on Wednesday by accusing Dr Anthony Fauci on the “Pod Force One” podcast of suppressing early scrutiny of COVID-19’s origins, calling the alleged effort a “massive cover-up” during the first months of the pandemic.
The Guardian - US · Nov 24, 2025 Doctors respond to ‘data-free’ decision over menopause hormone therapy: ‘It’s not true’ Physicians say FDA panel conflated two issues and made baseless claims about unproven health benefits
Benzinga · Nov 12, 2025 FDA Names Veteran Oncologist Richard Pazdur To Lead Drug Center After Ethics Scandal Ousts George Tidmarsh The U.S. Food and Drug Administration (FDA) has appointed Dr. Richard Pazdur as the new head of its drug center, succeeding Dr. George Tidmarsh, who was removed following an ethics complaint just months after his appointment.
International Business Times UK · Nov 11, 2025 Black Box Warning Facts: Why is the FDA Removing the Warning Label from Hormone Therapy Drugs The FDA has removed black box warnings from menopause hormone therapy drugs, marking a major milestone for women's health after decades of fear over outdated risks.
Roll Call · Nov 10, 2025 FDA removes warning for hormone replacement therapy for menopause - Roll Call The Food and Drug Administration is removing "black box" warnings on hormone replacement therapy for menopause.
The Independent UK · Nov 10, 2025 FDA will remove long-standing warning from hormone-based menopause drugs, citing benefits for women The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause symptoms in women
Benzinga · Nov 3, 2025 FDA Drug Chief George Tidmarsh Resigns After Allegations Of Power Misuse George Tidmarsh, head of the Food and Drug Administration’s (FDA) drug center, resigned Sunday following allegations that he misused his regulatory power to financially harm a former business associate.
The Independent UK · Oct 16, 2025 FDA unveils drugs to receive expedited review in support of 'national priorities' The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at the agency
The Independent UK · Oct 2, 2025 Trump administration approves generic version of abortion pill after RFK Jr had FDA review drug’s safety The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’
Axios · Oct 2, 2025 Conservatives rage after FDA approves generic abortion drug The decision adds to conservative scrutiny of the agency and Commissioner Marty Makary.